KR870000922B1 - Process for the preparation of a compound having antiulcer activity - Google Patents
Process for the preparation of a compound having antiulcer activity Download PDFInfo
- Publication number
- KR870000922B1 KR870000922B1 KR1019850001413A KR850001413A KR870000922B1 KR 870000922 B1 KR870000922 B1 KR 870000922B1 KR 1019850001413 A KR1019850001413 A KR 1019850001413A KR 850001413 A KR850001413 A KR 850001413A KR 870000922 B1 KR870000922 B1 KR 870000922B1
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- compound
- nitro
- mol
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Furan Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Description
본 발명은 다음 구조식(I)의 N-[2[[[5-(디메틸아미노)메틸]-2-푸라닐]메틸]티오]에틸]-N'-(3,4-메틸렌디옥시벤질)-2-니트로-1,1-에텐디아민의 제조 방법에 관한 것이다.The present invention relates to N- [2 [[[[5- (dimethylamino) methyl] -2-furanyl] methyl] thio] ethyl] -N '-(3,4-methylenedioxybenzyl) of formula (I) It relates to a process for producing 2-nitro-1,1-ethenediamine.
2-((2-아미노에틸)티오-메틸)-5-(디메틸아미노메틸)푸란의 1-니트로-2 -메틸티오-2-(3,4-메틸렌디옥시 벤질아미노)에텐과의 반응이 기재된 본 출원인의 이탈리아 공화국 특허출원 제235464A/81의 방법에 비하여 항궤양 활성이 높고, 실제로 독성이 없는 상기 구조식(I)의 화합물은 본 발명의 방법에서는 고수율과 고순도로 얻어질 수 있다.Reaction of 2-((2-aminoethyl) thio-methyl) -5- (dimethylaminomethyl) furan with 1-nitro-2-methylthio-2- (3,4-methylenedioxy benzylamino) ethene Compounds of the above formula (I), which have a high antiulcer activity and are virtually nontoxic, as compared to the method of Applicant's Italian Republic Patent Application No. 235464A / 81 described, can be obtained in high yield and high purity in the method of the present invention.
본 발명의 가장 적당한 실시 상태에 따르면, 다음 구조식(Ⅱ)의 2-(디메틸 아미노메틸)-5-(R-메틸)푸란이 다음 구조식(Ⅲ)의 화합물과 반응한다.According to the most suitable embodiment of the present invention, 2- (dimethyl aminomethyl) -5- (R-methyl) furan of the following formula (II) is reacted with a compound of the following formula (III).
위 각 식에서, R는 히드록시, 할로겐, 디메틸아미노 또는 트리메틸암모늄오요다이드이고, X는 O, S 또는 CH-NO2기이다.Wherein R is hydroxy, halogen, dimethylamino or trimethylammonium iodide and X is an O, S or CH-NO 2 group.
X가 CH-NO2기일 경우, 구조식(I)의 화합물은 직접 생성되지만, X는 O 또는 S일 경우에는, 구조식(Ⅱ)의 화합물과 구조식(Ⅲ)의 화합물을 반응시켜 얻은 화합물을 니트로메탄으로 처리하여, 구조식(I)의 화합물을 얻는다.When X is a CH-NO 2 group, the compound of formula (I) is produced directly, whereas when X is O or S, the compound obtained by reacting the compound of formula (II) with the compound of formula (III) is nitromethane. To obtain a compound of formula (I).
X가 CH-NO2인 일반식(Ⅲ)의 중간체는, 다음과 같은 반응 공정에 따라, 1-니트로-2,2-비스(메틸티오)에텐 또는 2-(니트로메틸렌)-티아졸리딘을 출발 물질로 사용하여 얻을 수 있다.Intermediates of formula (III), wherein X is CH-NO 2 , may be selected from 1-nitro-2,2-bis (methylthio) ethene or 2- (nitromethylene) -thiazolidine according to the following reaction process. Can be used as starting material.
[반응 공정 1][Reaction Step 1]
상기 반응 공정에 있어서, 구조식(Ⅳ)의 1-니트로-2,2-비스(메틸티오)에텐은 구조식(V)의 3,4-메틸렌디옥시벤질아민과 반응하여 구조식(Ⅵ)의 1-니트로-2-메틸티오-2-(3,4-메틸렌디옥시벤질아미노)에탄을 생성하는데, 이것을 암모니아 처리에 의하여 얻은 구조식(Ⅶ)의 N-(3,4-메틸렌디옥시벤질)-1-니트로에텐디아민에 에틸렌술피드를 첨가하면 중간체(Ⅲ)이 생성되는 것이다.In the reaction step, 1-nitro-2,2-bis (methylthio) ethene of formula (IV) reacts with 3,4-methylenedioxybenzylamine of formula (V) to form 1- of formula (VI). Nitro-2-methylthio-2- (3,4-methylenedioxybenzylamino) ethane is produced, which is N- (3,4-methylenedioxybenzyl) -1 of structural formula obtained by ammonia treatment. Addition of ethylene sulfide to nitroethenediamine produces intermediate (III).
다른 방법으로서는, 구조식(Ⅵ)의 화합물을 시스테아민 또는 2-아미노 에탄티올과 반응시킴으로써 직접 중간체(Ⅲ)을 얻을 수 있다.Alternatively, the intermediate (III) can be obtained directly by reacting the compound of formula (VI) with cysteamine or 2-amino ethanethiol.
아래의 반응 공정(2)에서는 구조식(Ⅳ)의 1-니트로-2,2-비스(메틸티오)-에텐을 암모니아로 처리하여 구조식(Ⅷ)의 1-니트로-2-아미노-2-메틸티오-에텐을 얻고, 이것을 에틸렌술피드와 반응시켜서 구조식(Ⅸ)의 1-니트로-2-메틸티오-2- (2-메르캅토에틸아미노)에텐을 얻고, 이어서 이것을 구조식(Ⅴ)의 3,4-메틸렌디옥시 -벤질아민으로 처리하여 구조식(Ⅲ)의 중간체를 얻는 공정을 나타내고 있다.In the following reaction step (2), 1-nitro-2,2-bis (methylthio) -ethene of formula (IV) is treated with ammonia to give 1-nitro-2-amino-2-methylthio of formula (VII). -An ethene is obtained and reacted with ethylene sulfide to obtain 1-nitro-2-methylthio-2- (2-mercaptoethylamino) ethene of the structural formula (VIII), which is then 3,4 of the structural formula (V) The process of obtaining the intermediate of Structural Formula (III) by treating with methylenedioxy-benzylamine is shown.
[반응 공정 2][Reaction Step 2]
구조식(Ⅸ)의 화합물은 구조식(Ⅱ)의 화합물 중의 하나와 반응하여 다음 구조식의 중간체,The compound of formula (VIII) reacts with one of the compounds of formula (II) to produce an intermediate of
을 생성하며, 이 중간체 화합물은 3,4-메틸렌디옥시-벤질아민(V)과의 반응에 의하여 화합물(I)을 생성할 수 있다.This intermediate compound can produce compound (I) by reaction with 3,4-methylenedioxy-benzylamine (V).
끝으로, 반응 공정 3에 따라, 구조식(Ⅹ)의 공지 화합물, 즉 2-(니트로메틸렌) -티아졸리딘[프랑스 특허 제2,384,765호, 독일 연방 공화국 공개 특허 공고 제2,734, 070호, 에스. 비. 솔로웨이(S. B. Soloway)등의 논문, Pestic. Venom, Neuz. -15°C ongr. Entom. 1976, 153(C.A. 89, 101812-1978) 및 Chem. Abstr. 99. 70613v 참조]을 구조식(V)의 3,4-메틸렌디옥시벤질아민과 반응시키면, 중간체(Ⅲ)을 훨씬 간단하고도 신속하게 얻을 수 있다.Finally, according to reaction step 3, known compounds of formula (i), ie 2- (nitromethylene) -thiazolidine [French Patent No. 2,384,765, Federal Republic of Germany Patent Publication No. 2,734,070, S. ratio. S. B. Soloway et al., Pestic. Venom, Neuz. -15 ° C ongr. Entom. 1976, 153 (C.A. 89, 101812-1978) and Chem. Abstr. 99. 70613v] can be obtained much more simply and quickly by reacting 3,4-methylenedioxybenzylamine of formula (V).
[반응 공정 3][Reaction Process 3]
X가 산소인 구조식(Ⅲ)의 중간체는, 하기 반응 공정에 의해서 구조식(V)의 3,4-메틸렌디옥시벤질아민을 N,N-카르보닐-디이미다졸과 반응시켜 구조식(Ⅸ)의 N-(3,4-메틸렌디옥시벤질)이미다졸-카르보닐아미드를 얻고, 이것을 회수하지 않고 직접 시스타민 또는 2-아미노에탄티올과 반응시키면 구조식(Ⅲ)의 목적하는 중간체 (X=O)가 생성된다.The intermediate of formula (III), wherein X is oxygen, reacts 3,4-methylenedioxybenzylamine of formula (V) with N, N-carbonyl-diimidazole by the following reaction step to Obtaining N- (3,4-methylenedioxybenzyl) imidazole-carbonylamide and reacting it directly with cystamine or 2-aminoethanethiol without recovery, the desired intermediate of formula (III) (X = O) Is generated.
유사한 방법으로, 아래의 반응 공정에 따라, 구조식(XI)의 N-(3,4-메틸렌디옥시벤질)이미다졸-카르보닐아미드를 시스테아민 또는 구조식(ⅩII)의 2,2'-디아미노디에틸디슬피드와 2 : 1의 비율로 반응하여, 구조식(XIII)의 2,2'-비스-(3,4-메틸렌디옥시벤질아미노카르보닐아미노에틸)디술피드를 생성하게 되는데, 이것을 아연 및 아세트산으로 간단히 환원시키면, 우레아(Ⅲ)이 보다 높은 수율로 생성될 수 있다.In a similar manner, N- (3,4-methylenedioxybenzyl) imidazole-carbonylamide of formula (XI) is converted to cysteamine or 2,2'-dia of formula (XII) according to the reaction process below. Reaction with minodiethyl disulfide in a ratio of 2: 1 yields 2,2'-bis- (3,4-methylenedioxybenzylaminocarbonylaminoethyl) disulfide of the formula (XIII), which is With simple reduction with zinc and acetic acid, urea (III) can be produced in higher yields.
2(XI)+H2N-CH2CH2-S-S-CH2CH2-NH2→2 (XI) + H 2 N-CH 2 CH 2 -SS-CH 2 CH 2 -NH 2 →
한편, X가 S인 구조식(Ⅲ)의 중간체는 3,4-메틸렌디옥시벤질이소티오시아네이트를 시스타민과 측합시켜 얻을 수 있다.On the other hand, an intermediate of formula (III) wherein X is S can be obtained by side-linking 3,4-methylenedioxybenzylisothiocyanate with cystamine.
구조식(Ⅱ)의 중간체는 공지되어 있으며, 이. 떠블유. 길(E. W. Gill)등의 논문(J. Chem. Soc. 1958, 4728)과 오. 몰덴하우어(O. Moldenhauer)등의 논문(Ann. 580, 169, 1953)에 기재된 공지 방법의 자명한 변경에 의하여 제조할 수 있다.Intermediates of formula (II) are known, and e. Subtle oil. E. W. Gill et al. (J. Chem. Soc. 1958, 4728) and o. It can manufacture by the obvious change of the well-known method described in the paper of O. Moldenhauer et al. (Ann. 580, 169, 1953).
화합물(I)을 제조하기 위한 상기 방법들 중의 한가지 변형법에 의하면, R가 염소 또는 히드록시인 구조식(Ⅲ)의 화합물을 R가 SH 인 화합물로 전환시킬 수 있다. 이 화합물은 화합물(Ⅶ) 또는 (Ⅷ)을 산화에틸렌과 반응시켜 얻을 수 있는 다음 구조식의 화합물,According to one of the above methods for preparing compound (I), the compound of formula (III) in which R is chlorine or hydroxy can be converted to a compound in which R is SH. This compound is a compound of the following structural formula obtained by reacting compound (iii) or (iii) with ethylene oxide,
과 반응할 수 있다.Can react with
가장 적합한 실시 상태에 의하면, 구조식(I)의 화합물은 다음 반응 고정에 따라 구조식(XIV)의 2-(디메틸아미메텔)-5-(2-히드록시)에틸티오메틸-푸란과 구조식 (Ⅶ)의 2-아미노-2-(3,4-메틸렌디옥시벤질아미노)-1-니트로-에텐(반응 공정 1)을 라니 니켈 존재하에 반응시킴으로써 제조될 수 있다.According to the most suitable embodiment, the compound of formula (I) is formulated with 2- (dimethylamimethel) -5- (2-hydroxy) ethylthiomethyl-furan of formula (XIV) according to the following reaction fixation. It can be prepared by reacting 2-amino-2- (3,4-methylenedioxybenzylamino) -1-nitro-ethene (reaction step 1) in the presence of Raney nickel.
화합물(XIV)는 임의로 대응하는 토실레이트로 전환시킨후, 화합물(Ⅶ)과 반응시킨다.Compound (XIV) is optionally converted to the corresponding tosylate and then reacted with compound (iii).
화합물(XIV) 및 그의 토실레이트는 이탈리아 공화국 특허 출원 제20461A/82에 지재되어 있다.Compound (XIV) and its tosylate are described in Italian Republic patent application 20461A / 82.
이하, 본 발명을 아래와 실시예에 의하여 더욱 구체적으로 설명한다.Hereinafter, the present invention will be described in more detail with reference to the following examples.
[실시예 1]Example 1
a) 1-니트로-2-(3,4-메틸렌디옥시벤질아미노)-2-(2-메르캅토에틸아미노)-에틸 [구조식Ⅲ (X=CH-NO)], 반응 공정1 )a) 1-nitro-2- (3,4-methylenedioxybenzylamino) -2- (2-mercaptoethylamino) -ethyl [Structure Formula III (X = CH-NO)], Reaction Step 1)
1-니트로-2,2-비스-(메틸티오)-에텐(33.05g, 0.2몰)을 1,1,2-트리클로로에틸렌(200㎖)에 첨가하고, 이 혼합물을 완전히 균질화될 때까지 환류시켰다. 이 비등 용액에 동일 용매(100㎖)중에 용해시킨 3,4-메틸렌디옥시벤질아민(15.1g, 0.1몰)을 첨가하였다. 이 반응 용액을 90분간 더 계속 환류시킨 다음, 용매를 감압 증류로 제거시키고, 수지 성분을 처음에는 석유 에테르로, 다음에는 디클로로메탄으로 전개시키는 실리카 겔 칼럼 크로마토그라피로 정제하였다.1-nitro-2,2-bis- (methylthio) -ethene (33.05 g, 0.2 mol) is added to 1,1,2-trichloroethylene (200 mL) and the mixture is refluxed until complete homogenization I was. To this boiling solution was added 3,4-methylenedioxybenzylamine (15.1 g, 0.1 mol) dissolved in the same solvent (100 mL). The reaction solution was further refluxed for 90 minutes, and then the solvent was removed by distillation under reduced pressure, and the resin component was purified by silica gel column chromatography, which was first developed with petroleum ether and then with dichloromethane.
1-니트로-2-메틸티오-2-(3,4-메틸렌디옥시벤질아미노)에텐(구조식 Ⅵ)을 디클로로메탄-에테르에서 결정화시켰다. 분석시 순수한 생성물 16.7g(수율 62%)을 얻었다. 용융 118。-119℃(보정하지 않았음).1-nitro-2-methylthio-2- (3,4-methylenedioxybenzylamino) ethene (formula VI) was crystallized in dichloromethane-ether. On analysis, 16.7 g (62% yield) of pure product were obtained. Melt 118 ° -119 ° C (not calibrated).
황(Schoeninger) : 계산치 11.95%, 실측치 12.00%.Schoeninger: calculated 11.95%, found 12.00%.
앞에서 얻은 화합물(15.0g, 0.056몰)을 진한 암모니아(200㎖)에 첨가하고, 이 반응 혼액을 실온에서 약 48시간 교반시켰다. 이 혼합물을 감압 증발시킨 후 생성된 조생성물을 후속 단계에서 사용하였다. 1-니트로-2-아미노-2-(3,4-메틸렌디옥시 벤질아미노)-에텐(구조식 Ⅶ)을 알코올, 바람직하게는 2-프트판올에서 결정화시켰다. 수득량 12.9g(수율 97%).The compound (15.0 g, 0.056 mol) obtained above was added to concentrated ammonia (200 mL), and the reaction mixture was stirred at room temperature for about 48 hours. The mixture was evaporated under reduced pressure and the resulting crude product was used in the next step. 1-nitro-2-amino-2- (3,4-methylenedioxy benzylamino) -ethene (formula VII) was crystallized in alcohol, preferably 2-ftpanol. Yield 12.9 g (97% yield).
상기 화합물의 메르캅토에틸화는 에이취. 알. 스나이더(H.R. Snyder)등의 논문 (J.Am. Chem. Soc. 69, 2672-1947)에 기재된 방법에 따라 에틸렌술피드를 사용하여 진행시켰다.Mercaptoethylation of the compound is H. egg. It proceeded using ethylene sulfide according to the method described in H. R. Snyder et al. (J. Am. Chem. Soc. 69, 2672-1947).
앞에서 얻은 1-니트로-2-아미노-2-(3,4-메틸렌디옥시 벤질아미노)-에텐 (11.8g, 0.05몰), 톨루엔(50㎖) 및 에틸렌술피드(3.0g, 0.05몰)를 가압하의 용기 중에서 혼합시켰다. 용기를 밀폐시킨 후, 그 혼합물을 90。-100℃에서 24시간 동안 교반 가열시켰다. 반응 혼액을 냉각시켜 감압 증류하여 조생성물을 얻고, 이것을 떠블유. 씨. 스틸(W. C. Still)등의 논문(J. Org. Chem. 43, 2923-1978)에 기재된 방법에 따라 정제하였다.1-nitro-2-amino-2- (3,4-methylenedioxy benzylamino) -ethene (11.8 g, 0.05 mol), toluene (50 ml) and ethylene sulfide (3.0 g, 0.05 mol) Mix in a vessel under pressure. After the vessel was sealed, the mixture was stirred and heated at 90 ° -100 ° C. for 24 hours. The reaction mixture was cooled and distilled under reduced pressure to obtain a crude product. Seed. Purification was carried out according to the method described in W. C. Still et al. (J. Org. Chem. 43, 2923-1978).
C12H15N3O4S(297.33)에 대한 원소 분석치 :Elemental Analysis for C 12 H 15 N 3 O 4 S (297.33):
계산치, % : C=48.47, H=5.07, N=14.13, S=10.78Calculated Value,%: C = 48.47, H = 5.07, N = 14.13, S = 10.78
실측치, % : C=48.62, H=5.12, N=14.10, S=10.52Found,%: C = 48.62, H = 5.12, N = 14.10, S = 10.52
b) 2-(디메틸 아미노메틸)-5-클로로메틸-푸란(구조식 Ⅱ, R=Cl)b) 2- (dimethyl aminomethyl) -5-chloromethyl-furan (formula II, R = Cl)
이, 떠블유. 길(E.W. Gill) 등의 논문(J. Chem. Soc. 1958, 4728)에 기재된 방법에 따라 제조한 2-(디메틸아미노메틸)-5-히드록시메틸푸란(15.6g, 0.1몰)을 디클로로메탄(100㎖)에 용해시키고, 그 용액을 실온하에 불균일상에서 처음에는 무수 염산으로, 다음에는 오염화인의 순서로 처리하였다. 약4시간 후, 염소화 반응이 완결되었다. 생성된 고체를 수집하고 여과기 위에서 디클로로메탄으로 충분히 세척하여 상기 할로겐화인을 제거하였다. 20% 수산화나트륨 수용액으로 순수하게 알칼리화하여 염기를 얻고, 이것을 디클로로메탄으로 수출시켰다. 유기 용액을 세척하고, 황산나트륨 (Na2SO4)으로 건조하여 증발시켜서, 유상 잔류물(4.0g, 수율 80.6%)을 얻었다. 염소(Schoeni nger) : 계산치 20.42%, 실측치 20.77%.Lee, you. 2- (dimethylaminomethyl) -5-hydroxymethylfuran (15.6 g, 0.1 mol) prepared according to the method described in EW Gill et al. (J. Chem. Soc. 1958, 4728) was converted to dichloromethane. (100 mL), and the solution was treated with hydrochloric anhydride first in heterogeneous phase at room temperature and then phosphorus pentachloride. After about 4 hours, the chlorination reaction was complete. The resulting solids were collected and thoroughly washed with dichloromethane on a filter to remove the phosphorus halide. Pure alkaline with 20% aqueous sodium hydroxide solution gave the base, which was exported to dichloromethane. The organic solution was washed, dried over sodium sulfate (Na 2 SO 4 ) and evaporated to afford an oily residue (4.0 g, yield 80.6%). Chlorine nger: calculated 20.42%, found 20.77%.
c) N-[2-[[[5-[(디메틸아미노)메틸]-2-푸라닐]메틸]티오]에틸]-N'- (3 , 4-메틸렌디옥시벤질)-2-니트로-1,1-에텐디아민(구조식 I)c) N- [2-[[[5-[(dimethylamino) methyl] -2-furanyl] methyl] thio] ethyl] -N'- (3, 4-methylenedioxybenzyl) -2-nitro- 1,1-ethenediamine (formula I)
나트륨 금속의 단편(1.15g, 0.05g.a.)들을 질소 분위기하에서 무수 에탄올 (200㎖)에 용해시켰다. 금속이 모두 용해되었을 때, 1-니트로-2-(3,4-메틸렌디옥시벤질아미노)-2-(2-메르캅토에틸아미노)에텐(14.8g, 0.05몰)을 첨가하였다. 이 혼합물을 약 20분 동안 환류 가열시킨 후, 방치하여 냉각시키고, 무수 에탄올(50㎖)중의 2-(디메틸아미노메틸)-5-클로로메틸-푸란(8.7g, 0.05몰)을 교반하에 서서히 첨가하였다.Fragments of sodium metal (1.15 g, 0.05 g.a.) were dissolved in anhydrous ethanol (200 mL) under nitrogen atmosphere. When all of the metal was dissolved, 1-nitro-2- (3,4-methylenedioxybenzylamino) -2- (2-mercaptoethylamino) ethene (14.8 g, 0.05 mol) was added. The mixture was heated to reflux for about 20 minutes, then left to cool, and 2- (dimethylaminomethyl) -5-chloromethyl-furan (8.7 g, 0.05 mol) in dry ethanol (50 mL) was added slowly under stirring. It was.
반응 혼액을 50°-80℃에서 약 2시간 가열하여 반응을 완결시키고, 동일한 온도에서 약간 혼탁해질 때까지 물을 첨가하였다. 반응 혼액을 냉각시킨 다음, 냉소에서 철야 방치하였다. 융점 98°-102℃(보정하지 않았음)의 결정질 생성물 16.3g(75%)을 회수하였다.The reaction mixture was heated at 50 ° -80 ° C. for about 2 hours to complete the reaction and water was added until slightly cloudy at the same temperature. After the reaction mixture was cooled, it was left overnight in a cold place. Recovered 16.3 g (75%) of crystalline product at melting point 98 ° -102 ° C. (not calibrated).
C20H26N4O5S (454.51)에 대한 원소 분석치 :Elemental Analysis for C 20 H 26 N 4 O 5 S (454.51):
계산치, % : C=55.29, H=5.69, N=12.90, S=7.05Calculated Value,%: C = 55.29, H = 5.69, N = 12.90, S = 7.05
실측치, % : C=55.39, H=6.02, N=12.79, S=7.10Found,%: C = 55.39, H = 6.02, N = 12.79, S = 7.10
1H-NMR 스펙트럼에 의하여 화합물의 구조를 확인하였다 (내부 표준 TMS, 용매 DMSO) 2,1,s,6H ; 2.7, m, 4H ; 3.4.s.2H ; 3.7,d,2H ; 3.85,s,2H ; 4.3,s,2H ; 6-7, m,6H 방향족 및 CHNO2 ; 8 및 10, s broad, 2H.The structure of the compound was confirmed by 1 H-NMR spectrum (internal standard TMS, solvent DMSO) 2,1, s, 6H; 2.7, m, 4H; 3.4.s.2H; 3.7, d, 2H; 3.85, s, 2 H; 4.3, s, 2H; 6-7, m, 6H aromatic and CHNO 2; 8 and 10, s broad, 2H.
이 화합물은 이탈리아 공화국 특허 출원 제23546A/81의 방법으로 제조되었던 것과 동일하였다.This compound was the same as was prepared by the method of Italian Republic patent application 23546A / 81.
[실시예 2]Example 2
a)1-니트로-2-(3,4-메틸렌디옥시벤질아미노)-2-(2-메르캅토에틸아미노 )-엔텐 [구조식Ⅲ (X=CH-NO2), 반응 공정 3]a) 1-nitro-2- (3,4-methylenedioxybenzylamino) -2- (2-mercaptoethylamino) -entene [Structure III (X = CH-NO 2 ), reaction step 3]
2-(니트로메틸)티아졸리딘(프랑스 특허 제2384765호, 독일 연방 공화국 공개 특허 공고 제2734070호, 에스. 비. 솔로웨이(S.B. Soloway)등의 논문, Pestic. veno m. neurotoxic. 153, 1976-C.A. 89,1018 12참조)(7.3g, 0.05몰)을 고비점 비극성 용매, 바람직하게는 톨루엔 또는 크실렌(100㎖)에 용해시켰다. 이 혼합물을 불활성 분위기 하에 환류시키고, 이어서 3,4-메틸렌디옥시벤질아민(15.1g, 0.1몰)을 30-40분에 걸쳐 적가하였다. 첨가가 끝나면, 약12시간 동안 환류를 계속하고, 이어서 그 반응 혼액을 냉각하여 여과시킨 후, 여액을 물, 10%묽은 염산 수용액, 물, 5% 수산나트륨 수용액, 이어서 다시 물의 순서로 세척하여 황산 마그네슘(MgSO4)으로 건조시키고, 용매를 진공 증발시켰다. 주로 조생성물로 이루어진 잔류물을 에틸 아세테이트-석유 에테르로 전개시키는 실리카 겔(70-230 메시)칼럼 크로마토그라피로 정제하였다. 분석상 순수한 화합물 10.1g(수율 68%)을 얻었다.2- (nitromethyl) thiazolidine (French Patent No. 2384765, German Federal Republic Publication No. 2734070, SB Soloway et al., Pestic. Veno m. Neurotoxic. 153, 1976 (See CA 89,1018 12) (7.3 g, 0.05 mol) was dissolved in a high boiling point nonpolar solvent, preferably toluene or xylene (100 mL). The mixture was refluxed under an inert atmosphere, and then 3,4-methylenedioxybenzylamine (15.1 g, 0.1 mol) was added dropwise over 30-40 minutes. After the addition, reflux was continued for about 12 hours, and then the reaction mixture was cooled and filtered, and then the filtrate was washed with water, an aqueous 10% dilute hydrochloric acid solution, water, an aqueous 5% sodium hydroxide solution, and then water again to give sulfuric acid. Dried over magnesium (MgSO 4 ) and the solvent was evaporated in vacuo. The residue, consisting mainly of crude product, was purified by silica gel (70-230 mesh) column chromatography, which was developed with ethyl acetate-petroleum ether. Analysis gave 10.1 g (68% yield) of pure compound.
C12H15N3O4S(297.33)에 대한 원소 분석치 :Elemental Analysis for C 12 H 15 N 3 O 4 S (297.33):
계산치, % : C=48.47, H=5.08, N=14.13, S=10.78Calculated Value,%: C = 48.47, H = 5.08, N = 14.13, S = 10.78
실측치, % : C=48.53, H=5.15, N=14.08, S=10.48Found,%: C = 48.53, H = 5.15, N = 14.08, S = 10.48
b) N-[2-[[[5-[(디메탈아미노)메틸]-2-푸라닐]메틸]티오]에틸]-N'- (2 , 4-메틸렌디옥시벤질)-2-니트로-1,1-에덴디아민 (구조식 I)b) N- [2-[[[5-[(dimetalamino) methyl] -2-furanyl] methyl] thio] ethyl] -N'- (2, 4-methylenedioxybenzyl) -2-nitro -1,1-Edendiamine (Formula I)
실시예 1에 기재된 것과 동일한 방법에 따라, 앞에서 제조된 중간체(Ⅲ)을 반응시켜서, 실시예 1의 것과 동일한 화합물을 얻었다. (수율 72%)According to the same method as described in Example 1, the intermediate (III) prepared above was reacted to obtain the same compound as in Example 1. (72% yield)
[실시예 3]Example 3
2,5-비스(디메틸아미노메틸)푸란 모노요오도 메틸레이트[구조식Ⅱ, R=N+( CH3)3I-]2,5-bis (dimethylaminomethyl) furan-mono-iodo methylate [Structure Ⅱ, R = N + (CH 3) 3 I -]
이. 떠블유. 길(E. W. Gill)등의 논문(J.Chem. Soc. 1958, 4728)에 기재된 방법에 따라 제조한 2,5-비스-(디메틸 아미노메틸)푸란(9.9g, 0.05몰)을 무수 아테토니트릴(100㎖)에 용해시켰다. 이 용액에 요오도메탄(7.1g, 0.05몰)을 적가하였다. 약 30분후, 사급 암모늄염이 결정화되기 시작하였는데, 이것을 수집하여 알코올, 바람직하게는 에탄올에서 결정화시켰다. (12.1g, 수율71%). 요오드(AgNO3) : 계산치 37.3% , 실측치 36.9%.this. Subtle oil. 2,5-bis- (dimethyl aminomethyl) furan (9.9 g, 0.05 mole) prepared according to the method described in EW Gill et al. (J. Chem. Soc. 1958, 4728) was subjected to anhydrous athetonitrile. (100 mL). Iodomethane (7.1 g, 0.05 mol) was added dropwise to this solution. After about 30 minutes, the quaternary ammonium salt began to crystallize, which was collected and crystallized in alcohol, preferably ethanol. (12.1 g, 71% yield). Iodine (AgNO 3 ): calculated 37.3%, found 36.9%.
b) N-[2-[[[5-(디메틸아미노)메틸]-2-푸라닐]메틸]티오]에틸]-N'- (3, 4-메틸렌디옥시벤질)-2-니트로-1,1-에텔디아민(구조식 I)b) N- [2-[[[5- (dimethylamino) methyl] -2-furanyl] methyl] thio] ethyl] -N'- (3, 4-methylenedioxybenzyl) -2-nitro-1 , 1-Ethyldiamine (formula I)
앞에서 얻은 요오드 메틸레이트(6.8g, 0.02몰)를 디메틸포름아미드(80㎖)에 용해시켰다. 실시예 2a)의 방법으로 제조된 1-니트로-2-(3,4-메틸렌디옥시 벤질아미노)-2-(2-메르캅토에틸아미노)에텐(5.9g, 0.02몰)을 첨가하였다. 반응 혼액을 80-120℃에서 불활성 분위기하에 약 1일 동안 교반 가열시켰다. 냉각시킨 후, 반응 혼액을 얼음물에 부어서, 고무질 고체를 분리시키고, 이것을 경사(傾瀉) 처리로 수집하여 물로 다시 세척한 후, 에탄올 수용액에서 결정화시켰다 (6.5g, 수율 72%), 융점 98。-102℃ (보정하지 않았음)Iodine methylate (6.8 g, 0.02 mole) obtained above was dissolved in dimethylformamide (80 mL). 1-nitro-2- (3,4-methylenedioxy benzylamino) -2- (2-mercaptoethylamino) ethene (5.9 g, 0.02 mol) prepared by the method of Example 2a) was added. The reaction mixture was stirred and heated at 80-120 ° C. under inert atmosphere for about 1 day. After cooling, the reaction mixture was poured into iced water to separate the rubbery solid, which was collected by decantation, washed again with water, and then crystallized in an aqueous ethanol solution (6.5 g, yield 72%), melting point 98 °- 102 ° C (not calibrated)
생성된 화합물은 실시예 1에서 제조된 것과 동일하였다.The resulting compound was the same as that prepared in Example 1.
[실시예 4]Example 4
a). 2-(디메틸 아미노메틸)-5-클로로메틸-푸란[구조식 Ⅱ(R=Cl)]a). 2- (dimethyl aminomethyl) -5-chloromethyl-furan [Formula II (R = Cl)]
오. 몰덴하우어(O. Moldenhauer)등의 논문(Ann. 580, 169-1953)에 기재된 방법으로 제조한 2,5-비스-(클로로메틸)푸란(16.5g, 0.1몰)을 에테르(200㎖)에 용해시키고, 디메틸아민 염산염(8.1g, 0.1몰)을 첨가하였다. 반응 혼액 0-5℃로 냉각시키고, 이어서 동일 온도를 계속 유지시키고, 각 첨가시마다 가스 발생이 멈추도록 조심해가면서, 격렬한 교반하에 무수 탄산칼륨(27.6g, 0.2몰)을 소량씩 첨가하였다. 첨가 조작이 종료되었을 때, 온도를 실온으로 승온시키고, 이어서 이 반응 혼액을 2시간 더 교반시켰다.Five. 2,5-bis- (chloromethyl) furan (16.5 g, 0.1 mol) prepared by the method described in O. Moldenhauer et al. (Ann. 580, 169-1953) was added to ether (200 mL). It was dissolved and dimethylamine hydrochloride (8.1 g, 0.1 mol) was added. The reaction mixture was cooled to 0-5 ° C., and then kept at the same temperature, and anhydrous potassium carbonate (27.6 g, 0.2 mol) was added in small portions under vigorous stirring while being careful to stop gas generation with each addition. When the addition operation was completed, the temperature was raised to room temperature, and then the reaction mixture was further stirred for 2 hours.
존재하는 무기염을 여과로 제거하고, 여액을 감압 증류시켰다. 비스-치환제의 불순물이 함유되어 있는 조생성물을 떠블유. 씨. 스틸(W. C. Still)등의 논문(J. Org. Chem. 43, 2923, 1978)에 기재된 방법에 따라 정제하였다.The inorganic salt present was removed by filtration and the filtrate was distilled off under reduced pressure. Crude oil containing impurities of bis-substituents. Seed. Purification was carried out according to the method described in W. C. Still et al. (J. Org. Chem. 43, 2923, 1978).
목적하는 순수 생성물은 거의 무색의 진한 오일 상태로 생성되었다(12.4g, 수율 72%)The desired pure product was produced as a nearly colorless dark oil (12.4 g, 72% yield).
염소(Schoeninger) : 계산치 20.42%, 실측치 20.33%.Chlorine: calculated 20.42%, found 20.33%.
b) N-[2-[[[5-[(디메틸아미노)메틸]-2-푸라닐]메틸]티오]에틸]-N'- (3 ,4-메틸렌디옥시벤질)-2-니트로-1,1-에텐디아민(구조식 I)b) N- [2-[[[5-[(dimethylamino) methyl] -2-furanyl] methyl] thio] ethyl] -N'- (3,4-methylenedioxybenzyl) -2-nitro- 1,1-ethenediamine (formula I)
실시예 1과 동일한 방법에 따라 실시예 1의 것과 동일한 구조식(I)의 화합물을 얻었다 (수율 81%).According to the same method as in Example 1, the compound of the formula (I) similar to that of Example 1 was obtained (yield 81%).
[실시예 5]Example 5
a). N-(2-메르캅토에틸))-N'-(3,4-메틸렌디옥시벤질)우레아 (구조식Ⅲ, X=O)a). N- (2-mercaptoethyl))-N '-(3,4-methylenedioxybenzyl) urea (formula III, X = O)
3,4-메틸렌디옥시 벤질아민(15. 1f, 0.1몰)과 N,N'-카르보닐디이미다졸(16. 2g, 0.1몰)을 무수 클로로포롬(200㎖)에 용해시켰다. 이 용액을 실온에서 약 30분동안 교반시키고, 이어서 무수 클로로포롬(50㎖) 중에 용해시킨 시스테아민 또는 2 -아미노에탄티올(7.7g, 0.1몰)을 첨가하였다. 반응 혼액을 30분동안 더 교반한 다음 여과시키고, 여액을 물, 10% 염산수용액, 물의 순서로 세척하여 황산마그네슘 (Mg SO4)으로 건조시킨 후, 용매를 증발시켰다. 생성된 조생성물을 에탄올-석유 에테르 혼합물에서 결정화시켜서, 분석상 순수한 생성물(13.2g, 수율 52%)을 얻었다.3,4-methylenedioxy benzylamine (15.1f, 0.1 mol) and N, N'-carbonyldiimidazole (16.2 g, 0.1 mol) were dissolved in anhydrous chloroform (200 mL). This solution was stirred for about 30 minutes at room temperature, followed by addition of cysteamine or 2-aminoethanethiol (7.7 g, 0.1 mol) dissolved in anhydrous chloroform (50 mL). The reaction mixture was further stirred for 30 minutes and then filtered, the filtrate was washed with water, 10% aqueous hydrochloric acid solution, and then dried over magnesium sulfate (Mg SO 4 ), and the solvent was evaporated. The resulting crude product was crystallized in ethanol-petroleum ether mixture to give analytical pure product (13.2 g, yield 52%).
황(Schoeninger) : 계산치 12.61%, 실측치 12.44%Schoeninger: calculated 12.61%, found 12.44%
2-아미노 에탄티올 대신에 시스타민 또는 2,2'-디아미노디에틸디술피드(구조식 XII)를 사용함으로써, 동일한 중간체를 유사한 방법으로 얻을 수 있으나, 상기 중간체를 보다 높은 수율(75-80%)로 얻을 수 있었따. 이어서, N,N'-비스-(3,4-메틸렌디옥시벤질)시스타민 (구조식 XIII)을 씨. 에프. 알렌(C. F. Allen)등의 논문 (Org. Synth. -coll. vol. Ⅱ. p. 580)에 기재된 방법으로 아연 및 초산을 사용해서 2몰의 메르캅탄으로 전환시켰다.By using cystamine or 2,2'-diaminodiethyldisulfide (formula XII) instead of 2-amino ethanethiol, the same intermediate can be obtained in a similar manner, but the intermediate is obtained in higher yield (75-80%). I could get it). Then, N, N'-bis- (3,4-methylenedioxybenzyl) citamine (formula XIII) was seeded. F. Zinc and acetic acid were used to convert 2 moles of mercaptan by the method described in C. F. Allen et al. (Org. Synth.-coll. Vol. II. P. 580).
b). N-[2-[[[5-[(디메틸아미노)메틸]2-푸라닐]메틸]티오]에틸]-N'-(3,4 -메틸렌디옥시벤질)우레아b). N- [2-[[[5-[(dimethylamino) methyl] 2-furanyl] methyl] thio] ethyl] -N '-(3,4-methylenedioxybenzyl) urea
나트륨 금속의 단편(0.6g, 0.025g. a.)들을 무수 에탄올(100㎖)에 용해시켰다. 금속이 모두 용해되었을때, 앞에서 제조된 N-(2-메르캅토에틸)-N'-(3,4-메틸렌디옥시벤질)우레아(6.35g, 0.025몰)를 첨가하였다. 반응 혼액을 15분 동안 교반 가열하여 냉각시킨 후, 무수 에탄올(20㎖)중의 2-(디메틸아미노-메틸)-5-클로로메틸푸란 (4.35g, 0.025몰)을 서서히 첨가하였다. 반응 혼액을 70℃로 약 2시간 동안 가열하여, 냉각시킨 다음, 반응 혼액이 약간 혼탁해질 정도로 물을 첨가하였다. 냉소에서 철야 방치 후, 결정체를 수집하고(7.40g, 수율 75.8%), 이것을 다음 단계에서 사용하였다. 시료를 원소 분석용으로 재결정화하였다.Fragments of sodium metal (0.6 g, 0.025 g. A.) Were dissolved in anhydrous ethanol (100 mL). When the metals were all dissolved, N- (2-mercaptoethyl) -N '-(3,4-methylenedioxybenzyl) urea (6.35 g, 0.025 mol) prepared previously was added. The reaction mixture was stirred and heated for 15 minutes to cool, then 2- (dimethylamino-methyl) -5-chloromethylfuran (4.35 g, 0.025 mol) in anhydrous ethanol (20 mL) was added slowly. The reaction mixture was heated to 70 ° C. for about 2 hours, cooled, and then water was added to the extent that the reaction mixture became slightly cloudy. After overnight incubation, the crystals were collected (7.40 g, yield 75.8%) and used in the next step. Samples were recrystallized for elemental analysis.
C19H25N3O4S (391.49)에 대한 원소 분석치 :Elemental Analysis for C 19 H 25 N 3 O 4 S (391.49):
계산치, % : C=58.29, H=6.43, N=10.73, S=8.18Calculated Value,%: C = 58.29, H = 6.43, N = 10.73, S = 8.18
실측치, % : C=58.52, H=6.25, N=10.79, S=8.10Found,%: C = 58.52, H = 6.25, N = 10.79, S = 8.10
c). N-[2-[[[5-[(디메틸아미노)메틸]-2-푸라닐]메틸]티오]에틸]-N'-(3, 4-메틸렌디옥시벤질)-2-니트로-1,1-에텐디아민 (구조식 I)c). N- [2-[[[5-[(dimethylamino) methyl] -2-furanyl] methyl] thio] ethyl] -N '-(3, 4-methylenedioxybenzyl) -2-nitro-1, 1-ethenediamine (Formula I)
니트로메탄(3.5g, 2.7㎖, 0.05몰)과 앞에서 제조된 우레아 유도체(19.5g, 0.05몰)를 얼음-염욕에 담근 플라스크에 넣고, 미리 냉각시킨 동일 용적의 물에 용해시킨 수산화나트륨(2.1g)의 수용액을 혼합물의 온도가 10。-15℃를 초과하지 않도록 서서히 첨가하였다. 첨가 도중에 생성되는 침전을 다른 메탄올로 희석시켰다.Nitromethane (3.5 g, 2.7 ml, 0.05 mole) and the urea derivative (19.5 g, 0.05 mole) prepared in the above were placed in a flask immersed in an ice-salt bath, and sodium hydroxide (2.1 g) dissolved in the same volume of water cooled beforehand. ) Aqueous solution was slowly added so that the temperature of the mixture did not exceed 10 ° -15 ° C. The precipitate produced during the addition was diluted with other methanol.
1시간 동안 교반 후, 묽은 염산을 중성으로 될 때까지 첨가하고, 이어서 반응 혼액이 약간 혼탁해질 정도로 물을 첨가하였다. 반응 혼액을 냉소에서 철야 방치시킨 후, 결정체를 수집하였다. 순도가 충분하지 못하므로, 에탄올 수용액에서 재결정화시켰다. (16.9g, 수율 77.8%). 융점 98。-102℃ (보정하지 않았음). 이 화합물은 실시예 1에서 얻은 것과 동일하였다.After stirring for 1 hour, dilute hydrochloric acid was added until neutral, and then water was added until the reaction mixture became slightly cloudy. After the reaction mixture was allowed to stand overnight in a cold place, crystals were collected. Since the purity was not sufficient, it was recrystallized in an aqueous ethanol solution. (16.9 g, yield 77.8%). Melting point 98 ° -102 ° C. (not calibrated). This compound was the same as obtained in Example 1.
[실시예 6]Example 6
a). 3,4-메틸렌디옥시벤질이소티오시아네이트a). 3,4-methylenedioxybenzylisothiocyanate
이황화탄소(38.1g, 30.2㎖, 0.5몰)과 물(45㎖)중의 수산화나트륨의 냉수용액 (20g, 0.5㎖)을 얼음탕에 담근 플라스크에 넣었다.A cold water solution (20 g, 0.5 mL) of carbon disulfide (38.1 g, 30.2 mL, 0.5 mol) and sodium hydroxide in water (45 mL) was placed in a flask immersed in an ice bath.
이 혼합물을 10-15℃에서 약 30분에 걸쳐 3,4-메틸렌디옥시벤질아민 (75g, 0.5㎖)에 첨가하였다. 반응 혼액을 30분 동안 더 교반시키고, 이어서 약 2시간 동안 환류시켰다. 반응 혼액을 35℃로 냉각시킨 후, 여기에 에틸 클로로카르보네이트 (54.2g, 47.5㎖, 0.5몰)를 서서히 첨가하고, 동일 온도에서 30분 동안 더 교반시켰다.This mixture was added to 3,4-methylenedioxybenzylamine (75 g, 0.5 mL) at 10-15 ° C over about 30 minutes. The reaction mixture was further stirred for 30 minutes and then refluxed for about 2 hours. After the reaction mixture was cooled to 35 ° C., ethyl chlorocarbonate (54.2 g, 47.5 mL, 0.5 mol) was slowly added thereto, and further stirred at the same temperature for 30 minutes.
반응 혼액이 실온으로 냉각되었을때, 이것을 분액 깔대기에 옮겨 상징액을 분리하여 황산나트륨(Na2SO4)으로 건조시킨 다음, 보다 휘발성인 부분을 35。-40℃에서 진공 제거하여, 후속 단계에서 사용하기에 충분한 순도의 생성물을 얻었다. (73.5g, 수율 76%)When the reaction mixture was cooled to room temperature, it was transferred to a separatory funnel, the supernatant was separated and dried over sodium sulfate (Na 2 SO 4 ), and the more volatile portion was then vacuumed at 35 ° -40 ° C. for use in subsequent steps. A product of sufficient purity was obtained. (73.5g, yield 76%)
b). N-(2-메르캅토에틸)-N'-(3,4-메틸렌디옥시벤질)우레아 (구조식Ⅲ, X =S)b). N- (2-mercaptoethyl) -N '-(3,4-methylenedioxybenzyl) urea (formula III, X = S)
디클로로메탄(80㎖)중의 3,4-메틸렌디옥시이소티오시아네이트(19.3g, 0.1몰)를 5℃로 냉각시켰다. 디클로로메탄(50㎖)으로 희석시킨 2-아미노에탄티올 (7.7g , 0.1몰)을 첨가하였다. 첨가는 반응액이 10℃를 초과하지 않도록 서서히 행하였다. 첨가 조작이 종료되었을 때, 1시간 동안 교반을 계속하여 온도를 실온으로 승온시켰다. 반응액을 분액 깔대기에 옳겨서, 물 10% 염산수용액, 물의 순서로 세척한 후, 황산마그네슘(MgSO4)으로 건조시키고, 이어서 여과 및 증발시켜서 잔류물인 조생성물을 얻고, 이것을 스틸 등의 논문(J. Org. Chem. 43, 2923-1978)에 기재된 방법으로 정제하였다. 생성물(18.4g, 수율 68%)은 후속 단계에서 사용하기에 충분한 순도를 가졌다.3,4-Methylenedioxyisothiocyanate (19.3 g, 0.1 mol) in dichloromethane (80 mL) was cooled to 5 ° C. 2-aminoethanethiol (7.7 g, 0.1 mol) diluted with dichloromethane (50 mL) was added. The addition was carried out slowly so that the reaction solution did not exceed 10 ° C. When the addition operation was completed, stirring was continued for 1 hour to raise the temperature to room temperature. The reaction solution was corrected in a separatory funnel, washed with 10% aqueous hydrochloric acid solution and water in that order, dried over magnesium sulfate (MgSO 4 ), and then filtered and evaporated to obtain a crude product as a residue. J. Org.Chem. 43, 2923-1978). The product (18.4 g, yield 68%) had sufficient purity for use in the next step.
황(Schoeninger) : 계산치 23.71%, 실측치 23.83%.Schoeninger: calculated 23.71%, found 23.83%.
c). N-[2-[[[5-[(디메틸아미노)메틸]-2-푸라닐]메틸]티오]에틸]-N'-( 3, 4-메틸렌디옥시벤질)티오우레아c). N- [2-[[[5-[(dimethylamino) methyl] -2-furanyl] methyl] thio] ethyl] -N '-(3,4-methylenedioxybenzyl) thiourea
앞에서 제조된 티오우레아를 실시예 5b)에 기재된 바와같이 소듐 에톡시드 존재하에 2-(디메틸 아미노메틸)-5-클로로메틸-푸탄(Ⅱ, R=Cl)과 반응시켜서 표제 화합물을 얻었다. (수율 77%).The thiourea prepared above was reacted with 2- (dimethyl aminomethyl) -5-chloromethyl-butane (II, R = Cl) in the presence of sodium ethoxide as described in Example 5b) to afford the title compound. (Yield 77%).
C19H25N3O3S2(407.55)에 대한 원소 분석치 :Elemental Analysis for C 19 H 25 N 3 O 3 S 2 (407.55):
계산치, % : C=55.99, H=6.18, N=10.31, S=15.73Calculated Value,%: C = 55.99, H = 6.18, N = 10.31, S = 15.73
실측치, % : C=60.11, H=5.99, N=10.29, S=15.56Found,%: C = 60.11, H = 5.99, N = 10.29, S = 15.56
d). N-[2-[[[5-[(디메틸아미노)메틸]-2-푸라닐]메틸]티오]에틸]-N'-( 3, 4-메틸렌디옥시벤질)-2-니트로-1,1-에렌디아민(구조식 I)d). N- [2-[[[5-[(dimethylamino) methyl] -2-furanyl] methyl] thio] ethyl] -N '-(3,4-methylenedioxybenzyl) -2-nitro-1, 1-erenediamine (formula I)
실시예 5c)와 동일한 방법을 수행하여, 구조식(I)의 화합물을 얻었다 (수율 81%). 이 화합물은 실시예 1에서 얻은 것과 동일하였다. 융점 98。-102℃, 융점(혼합) 98。-102℃.In the same manner as in Example 5c), the compound of formula (I) was obtained (yield 81%). This compound was the same as obtained in Example 1. Melting point 98 ° -102 ° C, melting point 98 ° -102 ° C.
Claims (4)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT19929A/84 | 1984-03-07 | ||
IT19929/84A IT1175808B (en) | 1984-03-07 | 1984-03-07 | PROCEDURE FOR THE PREPARATION OF COMPOUND WITH ANTI-ULTER ACTIVITY |
Publications (2)
Publication Number | Publication Date |
---|---|
KR850006409A KR850006409A (en) | 1985-10-05 |
KR870000922B1 true KR870000922B1 (en) | 1987-05-07 |
Family
ID=11162427
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019850001413A KR870000922B1 (en) | 1984-03-07 | 1985-03-06 | Process for the preparation of a compound having antiulcer activity |
Country Status (12)
Country | Link |
---|---|
KR (1) | KR870000922B1 (en) |
AR (1) | AR242955A1 (en) |
AT (1) | AT384610B (en) |
CA (1) | CA1227492A (en) |
DK (1) | DK157494C (en) |
ES (1) | ES8607291A1 (en) |
FI (1) | FI850554L (en) |
GR (1) | GR850398B (en) |
IT (1) | IT1175808B (en) |
NO (1) | NO850897L (en) |
PT (1) | PT80066B (en) |
ZA (1) | ZA851296B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110294696B (en) * | 2018-03-24 | 2021-07-02 | 复旦大学 | Thioethylurea/thiourea dimer derivatives, preparation method and medicinal application thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1168163B (en) * | 1981-08-18 | 1987-05-20 | Ausonia Farma Srl | COMPOUND WITH ANTI-ULTER ACTIVITY, PROCEDURE FOR ITS PREPARATION AND RELATIVE PHARMACEUTICAL COMPOSITIONS |
-
1984
- 1984-03-07 IT IT19929/84A patent/IT1175808B/en active
-
1985
- 1985-02-11 FI FI850554A patent/FI850554L/en not_active Application Discontinuation
- 1985-02-14 GR GR850398A patent/GR850398B/el unknown
- 1985-02-14 AT AT0043385A patent/AT384610B/en not_active IP Right Cessation
- 1985-02-19 DK DK075985A patent/DK157494C/en not_active IP Right Cessation
- 1985-02-20 ZA ZA851296A patent/ZA851296B/en unknown
- 1985-02-25 AR AR85299595A patent/AR242955A1/en active
- 1985-03-06 ES ES540987A patent/ES8607291A1/en not_active Expired
- 1985-03-06 PT PT80066A patent/PT80066B/en not_active IP Right Cessation
- 1985-03-06 NO NO850897A patent/NO850897L/en unknown
- 1985-03-06 KR KR1019850001413A patent/KR870000922B1/en not_active IP Right Cessation
- 1985-03-07 CA CA000475947A patent/CA1227492A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
NO850897L (en) | 1985-09-09 |
ES8607291A1 (en) | 1986-05-16 |
IT1175808B (en) | 1987-07-15 |
PT80066B (en) | 1987-09-30 |
PT80066A (en) | 1985-04-01 |
CA1227492A (en) | 1987-09-29 |
ES540987A0 (en) | 1986-05-16 |
ZA851296B (en) | 1985-10-30 |
DK75985D0 (en) | 1985-02-19 |
DK157494C (en) | 1990-06-11 |
ATA43385A (en) | 1987-05-15 |
KR850006409A (en) | 1985-10-05 |
GR850398B (en) | 1985-06-14 |
FI850554L (en) | 1985-09-08 |
FI850554A0 (en) | 1985-02-11 |
DK75985A (en) | 1985-09-08 |
AR242955A1 (en) | 1993-06-30 |
AT384610B (en) | 1987-12-10 |
DK157494B (en) | 1990-01-15 |
IT8419929A0 (en) | 1984-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1274523A (en) | Thiazolidine derivatives, their production and use | |
AU2005292984B2 (en) | Process for producing 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]ethyl]-1,3-propanediol hydrochloride or hydrate thereof and intermediate for the same | |
SU888821A3 (en) | Method of preparing 5-(substituted phehyl)-oxazolidinones or their sulphur-containing analogs | |
US4634701A (en) | Furan derivatives having anti-ulcer activity | |
KR100470887B1 (en) | 3-amino-2-mercaptobenzoic acid derivatives and processes for their preparation | |
EP0597102B1 (en) | Novel bisheterocyclic derivative or salt thereof and hypoglycemic composition | |
KR870000922B1 (en) | Process for the preparation of a compound having antiulcer activity | |
JPS6212776A (en) | Rhodanine derivative | |
IE880977L (en) | Nitroethane derivatives | |
KR0147820B1 (en) | Preparation of substituted ethenes | |
CA1208213A (en) | Process for producing heterocyclic compound having nitromethylene group as the side chain group | |
US5334725A (en) | 2-aminomethyl-4-exomethylenethiazoline epoxides | |
FR2482595A1 (en) | PROCESS FOR PREPARING N- (2 - (((5- (DIAL-KYLAMINO) -METHYL-2-FURANYL) -METHYL) -THIO) -ETHYL) -N'-ALKYL-2-NITRO-1,1-ETHENEDIAMINES AND SYNTHETIC INTERMEDIATES USED IN THIS PROCESS | |
CA1229619A (en) | Method for the synthesis of 5-thio-1,2,3-thiadiazole | |
KR820001991B1 (en) | Process for preparing furan derivatives | |
US6201127B1 (en) | Process for preparing benzyl-substituted rhodanine derivatives | |
EP0515121B1 (en) | Process for preparing intermediates to nizatidine and related compounds | |
US2899429A (en) | Nitroethylenes | |
KR900003882B1 (en) | Process for the preparation of compounds with h2 antihistamine activity | |
KR810000887B1 (en) | Process for preparing 1,1-disubstituted amino-2-nitro ethene derivatives | |
KR810000557B1 (en) | Process for preparation of thiochroman derivatives | |
JPS636063B2 (en) | ||
KR100471948B1 (en) | 3-amino-2-mercaptobenzoic acid derivatives and preparation method thereof | |
KR870000448B1 (en) | Process for preparing aminoalkyl furan derivatives | |
FR2491068A1 (en) | Prepn. of nitro-ethylene derivs. with antiulcer activity - from new 5-aminomethyl-furfuryl mercaptan and 1-amino-1-aziridinyl-2-nitro-ethylene derivs. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 19950420 Year of fee payment: 9 |
|
LAPS | Lapse due to unpaid annual fee |